Prosecution Insights
Prosecution Insights
Tech Center 3600 • Art Units: 3619 3626 3681 3683 3685 3687
This examiner grants 22% of resolved cases
SHELDEN, BION A is an examiner in Tech Center 3600 and Art Unit 3619. The data includes 325 resolved cases. The allowance rate is 22.5 percent, which reflects the frequency of grants for applications assigned to this examiner. Practitioners can use the 22.5 percent allowance rate to assess the likelihood of a positive outcome during prosecution. The 325 resolved cases provide a data set for analyzing the examiner's historical patterns in this specific technological area.
The interview lift is 18.7 percent. This metric indicates that the allowance rate is higher when an interview is conducted compared to the baseline rate of 22.5 percent. An interview lift of 18.7 percent suggests that direct communication is an effective strategy for overcoming rejections, especially given the low baseline rate. Practitioners should consider scheduling an interview to clarify technical issues or to negotiate claim scope. This 18.7 percent lift shows a clear benefit to verbal engagement with the examiner.
The median days to allowance is 1429. This number represents the middle point of the time required to reach a grant. A median of 1429 days provides a benchmark for the expected duration of the examination process. The combination of the 22.5 percent allowance rate and the 1429-day pendency defines the current prosecution environment for this examiner. These figures help applicants to manage expectations regarding both the timing and the probability of success.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18936944 | EXAMINATION SUPPORT APPARATUS, MEDICAL EXAMINATION APPARATUS, EXAMINATION SUPPORT METHOD, AND EXAMINATION SUPPORT PROGRAM | Non-Final OA | FUJIFILM Corporation |
| 18893974 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | Final Rejection | FUJIFILM CORPORATION |
| 18002549 | REMOTE CONFIGURATION OF A RESPIRATORY DEVICE | Non-Final OA | ResMed Pty Ltd |
| 18334342 | SYSTEMS AND METHODS FOR MONITORING SURGICAL WORKFLOW AND PROGRESS | Final Rejection | Stryker Corporation |
| 19228823 | DIGITAL IMAGING AND ARTIFICIAL INTELLIGENCE (AI)-BASED SYSTEMS AND METHODS FOR ANALYZING PRODUCT IMAGES | Non-Final OA | The Procter & Gamble Company |
| 19331478 | MEDICAL INFORMATION PROCESSING APPARATUS AND MEDICAL INFORMATION PROCESSING METHOD | Non-Final OA | Canon Kabushiki Kaisha |
| 19085040 | MEDICAL INFORMATION PROCESSING APPARATUS, MEDICAL INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM | Final Rejection | Canon Kabushiki Kaisha |
| 18015994 | CONNECTIONLESS DATA ALIGNMENT | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18086331 | SYSTEMS AND METHODS FOR OPTIMIZING RADIOTHERAPY PLANNING USING PLAN QUALITY SCORES | Non-Final OA | Siemens Healthineers International AG |
| 19294641 | Augmenting Knowledge Not Available in Electronic Health Record System Patient Charts | Non-Final OA | Oracle International Corporation |
| 19104909 | INFUSION SITE FAILURE DETECTION | Final Rejection | Eli Lilly and Company |
| 18906528 | SYSTEMS AND METHODS FOR INTELLIGENT MEDICAL EDITORS | Non-Final OA | GE Precision Healthcare LLC |
| 17932985 | DEMAND SIDE PLATFORM IDENTITY GRAPH ENHANCEMENT THROUGH MACHINE LEARNING (ML) INFERENCING | Final Rejection | ROKU, INC. |
| 18175057 | SYSTEMS AND METHODS FOR AUTOMATIC HEALTH DATA PROCESSING | Final Rejection | Optum, Inc. |
| 18474488 | MEDICAL CARE SUBJECT INFORMATION MANAGEMENT SYSTEM AND MEDICAL CARE SUBJECT INFORMATION MANAGEMENT PROGRAM | Final Rejection | TERUMO KABUSHIKI KAISHA |
| 17884768 | USING RESILIENT SYSTEMS INFERENCE FOR ESTIMATING HOSPITAL ACQUIRED INFECTION PREVENTION INFRASTRUCTURE PERFORMANCE | Non-Final OA | The Research Foundation for the State University of New York |
| 18891429 | DISEASE DIAGNOSIS METHOD USING TRAINED MODEL, AND SYSTEM CARRYING OUT SAME | Non-Final OA | THYROSCOPE INC. |
| 17902608 | AI BASED METHODS AND SYSTEMS FOR TRACKING CHRONIC CONDITIONS | Non-Final OA | CVS Pharmacy, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy